This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The best approach is to use social media to connect HCPs to clincial information and drugtrials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug. Doximity was flagged for having anti-vaccine information. Most said it had, but they still wanted to know more.
A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.
China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial.
That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. Dozens of companies are working at various stages of drug development. Others are not so fortunate. About the Author.
According to the FDA’s 2020 DrugTrials Snapshot Report , only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate. Keep it simple.
Pharmacovigilance refers to the practice of collecting, detecting, assessing, monitoring and preventing adverse effects (AEs) caused by new drug substances. After AEs are recorded, they must be translated and put back out to doctors and scientists for processing. Adapting pharmacovigilance to deal with surging case reports.
A major British medical school is leading the drive to eliminate what it calls “inherent racism” in the way doctors are trained in the UK. Exploring the fact that drugtrials predominantly involve white, male participants, and looking at how this may lead to inaccurate and harmful prescribing for other patients.
Clinical trials are studies involving human volunteers to research ways to prevent, detect, and treat various medical conditions. The goal is to identify safer, more effective methods of treating illnesses using new drugs or new combinations of existing drugs.
pic.twitter.com/dqmWPpxPdE — Adam Feuerstein (@adamfeuerstein) July 14, 2015 In another tweet, he suggests that the act will "decimate" informed consent in drugtrials. A drug manufacturer wants to understand physicians’ rationales for performing a certain procedure. Unbelievable but true if #Path2Cures becomes law.
Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. Educating potential Black trial participants about different trial models could help encourage greater participation.
Medical devices may be as complex as life-enhancing products implanted in patients or surgical assistance equipment, or items as simple as bandages, gloves, and other non-medication tools of a doctors trade, but as noted by one source , devices must go through various testing processes before they can be approved for patients.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content